[1. Robinson JK, Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol. 2003;139:643-48.10.1001/archderm.139.5.643]Search in Google Scholar
[2. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23:1118-26.10.1016/0190-9622(90)70344-H]Search in Google Scholar
[3. Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev. 2004;23:389-402.10.1023/B:CANC.0000031775.04618.30]Search in Google Scholar
[4. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ. 2004 Sep 25;329(7468):705. Epub 2004 Sep 13.]Search in Google Scholar
[5. Pennington BE, Leffell DJ. Mohs micrographic surgery: established uses and emerging trends. Oncology (Williston Park). 2005 Aug;19(9):1165-71; discussion 1171-2, 1175.]Search in Google Scholar
[6. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007 Aug;4(8):462-9.10.1038/ncponc0883]Search in Google Scholar
[7. Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Five-year followup of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007 Sep;143(9):1131-6.10.1001/archderm.143.9.1131]Search in Google Scholar
[8. Rowe DE, Carroll RJ, Day CL, Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-431.10.1111/j.1524-4725.1989.tb03249.x]Search in Google Scholar
[9. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol. 1998 Jul;39(1):79-97.10.1016/S0190-9622(98)70405-0]Search in Google Scholar
[10. Minton TJ. Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg. 2008 Aug;16(4):376-80. Review.10.1097/MOO.0b013e3283079cac]Search in Google Scholar
[11. Drake LA et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):271-8.10.1016/0190-9622(95)90261-9]Search in Google Scholar
[12. Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg 2005;62:518-526.10.1016/j.cursur.2005.01.00316125611]Search in Google Scholar
[13. Richmond JD, Davie RM. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg. 1987 Jan;40(1):63-7.10.1016/0007-1226(87)90013-0]Search in Google Scholar
[14. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999 Oct;135(10):1177-83. Review.10.1001/archderm.135.10.1177]Search in Google Scholar
[15. Silverman MK, Kopf AW, Bart RS,Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. 1992 Jun;18(6):471-6.10.1111/j.1524-4725.1992.tb03307.x]Search in Google Scholar
[16. Gulleth Y, Goldberg N, Silverman RP, Gastman BR. What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg. 2010 Oct;126(4):1222-31.10.1097/PRS.0b013e3181ea450d]Search in Google Scholar
[17. Wolf DJ, Zitelli JA: Surgical margins for basal cell carcinoma. Arch Dermatol. 1987;123:340-344.10.1001/archderm.1987.01660270078019]Search in Google Scholar
[18. Staub G, Revol M, May P. 2007 Oct 24. Excision skin margin and recurrence rate of skin cancer: a prospective study of 844 cases. Ann Chir Plast Esthet. 2008 Oct;53(5):389-98. Epub]Search in Google Scholar
[19. Smeets NW, Krekels GA, Ostertag JU Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004 Nov 13-19;364(9447):1766-72.10.1016/S0140-6736(04)17399-6]Search in Google Scholar
[20. Berlin J, Katz KH, Helm KF, Maloney ME. The significance of tumor persistence after incomplete excision of basal cell carcinoma. J Am Acad Dermatol. 2002 Apr;46(4):549-53.10.1067/mjd.2002.117733]Search in Google Scholar
[21. Sei JF. Marges d’exerese et reprise dans les carcinomes cutanes. Ann Dermatol Venereol 1997;124:421-426.]Search in Google Scholar
[22. Wilson AW, Howsam G, Santhanam V, et al. Surgical management of incompletely excised basal cell carcinomas of the head and neck. Br J Oral Maxillofac Surg. 2004;42:311-314.10.1016/j.bjoms.2004.02.030]Search in Google Scholar
[23. Bogdanov-Berezovsky A, Cohen A, Glesinger R, Clinical and pathological findings in reexcision of incompletely excised basal cell carcinomas. Ann Plast Surg. 2001 Sep;47(3):299-302.10.1097/00000637-200109000-00013]Search in Google Scholar
[24. Robinson JK, Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol. 2000;136:1318-24.]Search in Google Scholar
[25. Goldberg DP. Assessment and surgical treatment of basal cell skin cancer. Clin Plast Surg. 1997 Oct;24(4):673-86.10.1016/S0094-1298(20)32290-2]Search in Google Scholar
[26. Newman JC, Leffell DJ. Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma. Dermatol Surg. 2007 Aug;33(8):957-64; discussion 965.10.1111/j.1524-4725.2007.33198.x]Search in Google Scholar
[27. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8.10.1016/S0190-9622(08)81509-5]Search in Google Scholar
[28. Chen J, Ruczinski I, Jorgensen TJ, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 3;100(17):1215-22. Epub 2008 Aug 26.10.1093/jnci/djn260272071318728282]Search in Google Scholar